Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study

Summary

In Norway, more than 11,000 patients undergo percutaneous coronary intervention (PCI) annually. However, a very recent study utilizing registry data show a national average of cardiac rehabilitation (CR) participation of only 14%, despite its proven beneficial effects on readmissions, physical capacity, psychological distress, self-management, and quality of life. CR is strongly recommended in European guidelines. However, uptake is low and is not systematically identifying those in most need of CR. The primary objective of eCardiacRehab is to meet rehabilitation needs of large patient populations regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and comprehensive home-based eCardiacRehab programme. eCardiacRehab address patient- and system level challenges in order to increase access to CR. The investigators give particular attention to older patients, women, and those with comorbidities or mental health challenges. Aspects related to continuity of care between specialist and primary care services, health literacy, adherence to treatment, cost effectiveness and ethics are investigated. The investigators will 1) continue to develop the programme with patients, general practitioners, healthcare experts from both specialist and primary care services, and technology developers, 2) develop treatment modules, 3) establish information and communication infrastructure, 4) evaluate the process and efficacy of treatment modules, 5) ensure knowledge development and transfer of competence to the municipalities, and 6) contribute to fulfil the innovation potential for health service and industry partners. eCardiacRehab has the potential to improve interaction and collaboration between primary and secondary care, modernise and digitalise work processes, and develop more coherent and tailored patient pathways. The vision of the home-based eCardiacRehab is to make CR available to all.

Conditions

• Coronary Artery Disease
• Cardiac Rehabilitation
• Ethics
• Continuity of Patient Care
• Older Adults (65 Years and Older)
• Cost-Benefit Analysis
• Adherence, Medication
• Adherence, Treatment
• Health Literacy
• eHealth Literacy
• Mental Health
• Secondary Prevention of Coronary Heart Disease
• Comorbidities
• Hypertension
• Physical Activity
• Women

Interventions

OTHER

eCardiacRehab

Interdisciplinary supervised home-based digital secondary prevention programme (12-week programme) based on the European Society of Cardiology guidelines for cardiac rehabilitation for patients after percutaneous coronary intervention.

Sponsors & Collaborators

• The Research Council of Norway

  collaborator OTHER

• Helse Vest

  collaborator OTHER

• Helse Fonna

  collaborator OTHER

• Helse Møre og Romsdal HF

  collaborator OTHER_GOV

• Helse Vest IKT

  collaborator UNKNOWN

• Western Norway University of Applied Sciences

  collaborator OTHER

• Youwell

  collaborator UNKNOWN

• University of Bergen

  collaborator OTHER

• Østfold University College

  collaborator UNKNOWN

• Norsk råd for digital etikk

  collaborator UNKNOWN

• Helse Førde HF

  collaborator UNKNOWN

• University of Amsterdam

  collaborator OTHER

• Center for Research on Cardiac Disease in Women

  collaborator UNKNOWN

• Nasjonal kompetansetjeneste Trening som medisin

  collaborator UNKNOWN

• RELIS Vest

  collaborator UNKNOWN

• Norwegian Centre for E-health Research

  collaborator UNKNOWN

• Bergen Municipality

  collaborator UNKNOWN

• Sunnfjord Municipality

  collaborator UNKNOWN

• Sogndal Municipality

  collaborator UNKNOWN

• Masfjorden Municipality

  collaborator UNKNOWN

• The Norwegian Heart and Lung Patient Organization

  collaborator UNKNOWN

• E-helse Vestland

  collaborator UNKNOWN

• Yale University

  collaborator OTHER

• University of Sydney

  collaborator OTHER

• University of Cambridge

  collaborator OTHER

• University of Regina

  collaborator OTHER

• University of Copenhagen

  collaborator OTHER

• Linkoeping University

  collaborator OTHER_GOV

• Voss Hospital, Norway

  collaborator UNKNOWN

• Haukeland University Hospital

  lead OTHER

Principal Investigators

• Tone M Norekvål, PhD · Haukeland University Hospital

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-01-06

Primary Completion

2025-10-30

Completion

2035-10-30

Countries

• Norway

Study Locations